Catarina Pulido

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz et al. · European Journal of Cancer · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases

André Mansinho, Arlindo R. Ferreira, Sandra Casimiro et al. · International Journal of Molecular Sciences · 2019 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases

Arlindo R. Ferreira, M. Bettencourt, Irina Alho et al. · Journal of bone oncology · 2017 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +15

Lymph node yield in the pathological staging of resected nonmetastatic colon cancer: The more the better?

Pedro Simões, Gonçalo Fernandes, Beatriz Costeira et al. · Surgical Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Surgery +17

Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer

I. Vendrell, Arlindo R. Ferreira, André Abrunhosa-Branquinho et al. · Medicine · 2018 · 12 citations · Full text

Medicine, Oncology, Radiation Oncology +15